{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:24:37Z","timestamp":1773393877864,"version":"3.50.1"},"reference-count":23,"publisher":"Informa UK Limited","issue":"16","funder":[{"DOI":"10.13039\/100018536","name":"NuCana PLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018536","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.2217\/fon-2020-0247","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T16:15:25Z","timestamp":1588781725000},"page":"1069-1081","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["NUC-1031\/cisplatin versus gemcitabine\/cisplatin in untreated locally advanced\/metastatic biliary tract cancer (NuTide:121)"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-3678","authenticated-orcid":false,"given":"Mair\u00e9ad Geraldine","family":"McNamara","sequence":"first","affiliation":[{"name":"Division of Cancer Sciences,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipika","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Massachusetts General Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sunnybrook Health Sciences Centre,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Springfeld","sequence":"additional","affiliation":[{"name":"Heidelberg University Hospital, Medical Oncology, National Center for Tumor Diseases","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sidney Kimmel Comp Cancer Center, The Johns Hopkins Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin Marie","family":"Sjoquist","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center,","place":["Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Verdaguer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Vall d\u2019Hebron Institute of Oncology","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Braconi","sequence":"additional","affiliation":[{"name":"The University of Glasgow & the Beatson West of Scotland Cancer Centre","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Guy\u2019s Hospital","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimery De","family":"Gramont","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Franco-British Institute","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Raymond","family":"Zalcberg","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Alfred Health & School of Public Health,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan W","family":"Valle","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J","family":"Knox","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199610000-00005"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw324"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065144"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.4_suppl.477"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605779"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603559"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401853a"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44089-3"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0244-1"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"issue":"8","key":"e_1_3_4_17_1","first-page":"viii205","article-title":"A new ProTide, NUC-1031, combined with cisplatin for the first-line treatment of advanced biliary tract cancer (ABC-08)","volume":"29","author":"McNamara MG","year":"2018","unstructured":"McNamaraMG, BridgewaterJ, PalmerDet al.A new ProTide, NUC-1031, combined with cisplatin for the first-line treatment of advanced biliary tract cancer (ABC-08).Annals of Oncol.29(Suppl. 8), viii205\u2013viii270 (2018).","journal-title":"Annals of Oncol."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606086"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0322-4"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2307\/2336502"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.00853.x"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00139-4"},{"key":"e_1_3_4_24_1","unstructured":"European Medicines Agency (EMA). ICH Topic E 9 statistical principles for clinical trials (1998). www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-9-statistical-principles-clinical-trials-step-5_en.pdf"},{"key":"e_1_3_4_25_1","unstructured":"US FDA. FDA guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics (2018). www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-trial-endpoints-approval-cancer-drugs-and-biologics"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2020-0247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:28:17Z","timestamp":1744064897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2020-0247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.2217\/fon-2020-0247"],"URL":"https:\/\/doi.org\/10.2217\/fon-2020-0247","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}